New Lucentis pricing to increase NHS prescriptions
pharmafile | August 29, 2008 | News story | Sales and Marketing |Â Â Lucentis, ophthÂ
Related Content
Novartis’ Lucentis secures European approval for infants with rare eye disease
Novartis has made the surprise announcement that its VEGF inhibitor Lucentis (ranibizumab) has been awarded …
Roche’s eye drug beats Lucentis at Phase 2 in wet age-related macular degeneration
Roche has revealed positive new Phase 2 data for faricimab (RG7716) in the treatment of …
Roche granted further good news by FDA
Roche was given further good news by FDA after receiving a Priority Review for its …
